Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
---|
09/08/2009 | US7585515 Curable mixture of a bone substitute, a dianhydride of a dicarboxylic acid and an unsaturated carboxylic acid (dimethacrylic anhydride of sebacic acid and/or 1,3-bis(p-carboxyphenoxy)propane), photoinitiator, and redox catalyst; dental, orthopedic and drug delivery applications |
09/08/2009 | CA2386770C Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
09/03/2009 | US20090221546 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
09/03/2009 | US20090220550 Vaccines for Mycoplasma bovis and methods of use |
09/03/2009 | US20090220535 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection |
09/03/2009 | US20090220424 Pro104 Antibody Compositions and Methods of Use |
09/02/2009 | EP1677703A4 Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials |
09/02/2009 | EP1651648A4 Compounds and compositions as protein kinase inhibitors |
09/02/2009 | EP1620056B1 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
09/02/2009 | CN101519449A Modified transferrin fusion proteins |
09/02/2009 | CN100534411C Oxidation dyeing method using N-acetylcysteine as reducing agent and laccase as oxidating agent |
09/01/2009 | US7582733 Modified immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease; immunotherapy |
09/01/2009 | US7582726 cancer therapy utilizing novel vascular endothelial cell growth factor receptor antagonists; immunoglobulin like domain from kinase domain receptor; nucleic acid encoding prolactin receptor antagonizing domain, a VEGF ligand and a cytokine; cell based assay; |
09/01/2009 | US7582478 Cleaved serum response factor in cardiac diagnosis and therapy |
09/01/2009 | US7582297 Methods of treating respiratory conditions |
08/27/2009 | US20090215982 Glycopeptide derivatives and pharmaceutical compositions containing the same |
08/27/2009 | US20090215825 Substituted pyrazoles, compositions containing such compounds and methods of use |
08/27/2009 | US20090215795 Cyclic amidine derivatives |
08/27/2009 | US20090215067 Novel lipids for transfection of nucleic acids |
08/27/2009 | US20090214505 For treating an excess of a substrate for a hyaluronidase, such as reducing scar tissue |
08/27/2009 | US20090214470 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
08/26/2009 | EP1462442B1 Crystals of bicalutamide and process for their production |
08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
08/26/2009 | EP1147212B1 T helper cell epitopes |
08/26/2009 | CN101514223A Method for preparation of site-specific protein conjugates |
08/25/2009 | US7579473 c-Met modulators and methods of use |
08/25/2009 | US7579363 Bicyclic compounds and compositions as PDF inhibitors |
08/25/2009 | US7579355 Inhibitors of Akt activity |
08/25/2009 | US7579316 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent |
08/25/2009 | US7579023 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
08/25/2009 | CA2439078C Composition improving age-related physiological deficits and increasing longevity |
08/20/2009 | US20090209595 Method of treating of demyelinating diseases or conditions |
08/20/2009 | US20090209594 Method of treating of demyelinating diseases or conditions |
08/20/2009 | US20090209593 Novel antibacterial agents |
08/20/2009 | US20090209505 Prodrugs of heteroaryl compounds |
08/20/2009 | US20090208620 Alimentary Compositions and Methods For Metabolic Modulation |
08/20/2009 | US20090208451 Halogen phosphonate monoesters |
08/19/2009 | EP1485393B1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
08/19/2009 | CN100528229C Method of inhibiting tumor growth with anti-tissue factor antibodies |
08/18/2009 | US7576127 Aromatic prodrugs of propofol, compositions and uses thereof |
08/18/2009 | US7576122 Ophthalmic compositions for treating ocular hypertension |
08/18/2009 | US7576101 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
08/18/2009 | US7576052 Methods and compositions for modulating adipocyte function |
08/18/2009 | US7575752 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
08/18/2009 | US7575747 Antibodies, or fragments thereof, that are humanized variants of murine antibody 266 which employ complementarity determining regions derived from murine antibody 266; useful for treatment or prevention of conditions associated with A beta, including Alzheimer's disease, Down's syndrome |
08/18/2009 | US7575741 Using interleukin-23 modulators to enhance wound healing |
08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
08/13/2009 | US20090203896 Modulation of survivin expression |
08/13/2009 | US20090203638 Pharmaceutical compositions and methods for metabolic modulation |
08/13/2009 | US20090202618 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
08/12/2009 | EP1675579B1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
08/12/2009 | EP1636221B1 3-Heterocyclyl-Azetidine compounds useful as NK1/NK2 receptors antagonists |
08/12/2009 | EP1592760A4 Solid dispersion compositions |
08/12/2009 | CN101502648A 疫苗 Vaccine |
08/12/2009 | CN100526374C Use of a plastic composition and a product obtained thereby |
08/12/2009 | CN100525835C Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
08/11/2009 | US7572922 Substituted pyrazoles, compositions containing such compounds and methods of use |
08/11/2009 | US7572904 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines |
08/11/2009 | US7572828 Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
08/11/2009 | US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
08/11/2009 | US7572804 Macrolides |
08/11/2009 | US7572787 Substituted naphthalene sulfonamides |
08/11/2009 | US7572470 Licorice extract for use as a medicament |
08/11/2009 | US7572462 Peri-operative and peri-procedure nutritional supplementation |
08/11/2009 | US7572454 From Canine Distemper Virus; vaccines; luteinizing hormone releasing hormone |
08/11/2009 | US7572443 Anti-Platelet endothelial cell adhesion molecule (PECAM); monoclonal antibodies; kits |
08/11/2009 | CA2331393C Fatty acid analogues for the treatment of primary and secondary restenosis |
08/06/2009 | US20090197802 Analogues of GLP-1 |
08/05/2009 | EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade |
08/05/2009 | EP2085096A2 Novel composition and methods for the treatment of immune related diseases |
08/05/2009 | EP1670519A4 Radiolabeled thymidine solid-phase extraction purification method |
08/05/2009 | EP1624884A4 Somatostatin vectors |
08/05/2009 | EP1399445B1 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
08/05/2009 | EP1249233B9 Npyy5 antagonists |
08/05/2009 | CN101497581A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
08/05/2009 | CN100523192C Vaccines from infectious agents |
08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
08/05/2009 | CN100522949C Piperazinedione compounds |
08/05/2009 | CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
08/05/2009 | CN100522164C Method of treating of demyelinating diseases or conditions |
08/04/2009 | US7569593 Compounds and compositions as protein kinase inhibitors |
08/04/2009 | US7569554 Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents |
08/04/2009 | US7569549 Crystallizing in water-miscible solvent, water, and mineral/organic acid |
08/04/2009 | US7569215 Mutant interleukin-2 (IL-2) polypeptides |
08/04/2009 | CA2536251C Novel crystalline forms of a phosphoric acid salt of a dipeptidyl peptidase-iv inhibitor |
08/04/2009 | CA2411047C Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
07/30/2009 | US20090192189 Treatment of cancers expressing p95 erbb2 |
07/30/2009 | US20090192099 Prodrugs of heteroaryl compounds |
07/30/2009 | US20090192074 Methods and pharmaceutical compositions for healing wounds |
07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
07/30/2009 | US20090188491 Medicaments |
07/29/2009 | EP1653955A4 Hydroxylamine substituted imidazo-containing compounds |
07/29/2009 | EP1628663B1 Method for producing medicaments for reducing amyloid deposition, amyloid neurotoxicity and microgliosis |
07/29/2009 | CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists |
07/29/2009 | CN100518814C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into biological environmentat from polymer matrix |
07/28/2009 | US7566727 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-furo[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor |
07/28/2009 | US7566710 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |